Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / Madison Avenue Partners acquires...
Business shareholding acquisition

Madison Avenue Partners acquires Lakefront shares

Analysis based on 6 articles · First reported Jun 29, 2026 · Last updated Jun 29, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market may react positively to the news of Madison Avenue Partners' significant investment in Lakefront Biotherapeutics, potentially leading to an increase in Lakefront Biotherapeutics' stock price due to increased investor confidence. This acquisition signals a belief in the long-term value and potential of Lakefront Biotherapeutics' pipeline.

Biotechnology Investment Management
Event Summary

Madison Avenue Partners, LP, along with its affiliates Madison Avenue International, LP, EMAI Management, LLC, and Eli Samaha, acquired 3,498,892 voting rights in Lakefront Biotherapeutics NV. This acquisition, which occurred on June 15, 2026, resulted in Madison Avenue Partners crossing the 5% ownership threshold, now holding 5.31% of Lakefront Biotherapeutics' outstanding shares. Lakefront Biotherapeutics, a biotechnology company, received a transparency notification regarding this change in major shareholdings, as required by Belgian transparency legislation.

Entities Involved
priv
Madison Avenue Partners
Madison Avenue Partners, LP, jointly with its affiliates, acquired 5.31% of Lakefront Biotherapeutics' voting rights, indicating a significant investment in the biotechnology company.
Importance 100.0 Sentiment 10.0
priv
Lakefront Biotherapeutics
Lakefront Biotherapeutics received a transparency notification that Madison Avenue Partners, LP, along with its affiliates, acquired voting rights, crossing the 5% ownership threshold. This indicates increased investor interest in the company.
Importance 100.0 Sentiment 10.0
per
Eli Samaha
Eli Samaha is associated with Madison Avenue Partners, LP, and was part of the group that crossed the 5% voting rights threshold in Lakefront Biotherapeutics.
Importance 50.0 Sentiment 10.0
cnt
Belgium
The event is regulated by Belgian transparency legislation, as Lakefront Biotherapeutics is based in Mechelen, Belgium.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.